Vascular Risk Clinical Trials in Barcelona
3 recruitingBarcelona, Spain
Showing 1–3 of 3 trials
Recruiting
Phase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
HypertensionHigh Risk Cardiovascular DiseaseHigh Cardiovascular Risk
Alnylam Pharmaceuticals11,000 enrolled597 locationsNCT07181109
Recruiting
Phase 3
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular RiskAcute Myocardial Infarction (AMI)
Novo Nordisk A/S10,000 enrolled970 locationsNCT06118281
Recruiting
Not Applicable
Impact of Mediterranean Diet in Cardiovascular Risk Among People With HIV
HIV InfectionCardiovascular RiskInflammation+1 more
Parc de Salut Mar64 enrolled1 locationNCT06757309